Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep41 | Adrenal and Cardiovascular Endocrinology | ECE2020

Somatostatin receptors 2A and 5 expression in adrenocortical cancer

Roslyakova Anna , Selivanova Lilia , Tarasova Arina , Beltsevich Dmitry

Introduction: Adrenocortical carcinoma (ACC) is a rare malignant tumor with heterogeneous prognosis. The median overall survival of all ACC patients is about 3-4 years. Complete surgical resection provides the only cure [Fassnacht M, et al., 2018]. In cases of advanced ACC, therapeutic options are limited. No effective second-line therapies are recommended for patients with disease progression to EDP chemotherapy scheme and Mitotane. It is essential to study alternative drugs,...

ea0099ep550 | Thyroid | ECE2024

Clinical case of a combination of giant prolactinoma and medullary thyroid cancer

Perepelova Margarita , Przhiyalkovskaya Elena , Pigarova Ekaterina , Nikiforovich Petr , Selivanova Lilia , Roslyakova Anna , Shutova Aleksandra , Dzeranova Larisa

Background: The combination of various endocrine tumours is presented both as hereditary syndromes and sporadic forms. Medullary thyroid cancer and prolactinoma are neuroendocrine tumours, the presence of these two pathologies simultaneously has not been previously described in the literature.Objective: To present a clinical case of a patient with giant prolactinoma and medullary thyroid cancer.Materials and Methods: To describe th...